Evidence check: Cardio Risk Check in the context of Schlaf

The evidence for a 'Cardio Risk Check' in the context of sleep is currently 'mixed'. There are well-established links between sleep duration, sleep quality, and cardiovascular risk factors such as hypertension, inflammation, and metabolic syndrome. However, most direct-to-consumer tests (e.g., genetic panels for cardiovascular risk) are not specifically validated for sleep-related outcomes. Some genetic variants, such as APOE ε4 (rs429358), are associated with elevated LDL cholesterol and Alzheimer risk, but their interaction with sleep is not sufficiently validated in human studies. The Fitness VITALITY DNA tests analyze markers for metabolism and performance, but without strong prediction for sleep-related cardiovascular risks. The clinical utility of such tests remains limited; lifestyle factors (sleep hygiene, diet, exercise) have a far greater impact. Consumers should not rely on these tests as a sole basis for health decisions. A physician consultation and established risk scores (e.g., PROCAM, SCORE) are recommended.